Morepen Labs’ Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time Business Morepen Labs’ Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time newsyweb.com April 20, 2026 0 Post Views: 2 Gurugram, Haryana, India: Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has announced the successful completion... Read More Read more about Morepen Labs’ Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time
